Clinical trial
A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on…
NCT00442702 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00442702 |
|---|---|
| Title | A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. |
| Official title | An Open-label, Randomized, Multi-center, Parallel Group Non-inferiority Study of Subcutaneous Injections of RO0503821 Given Once Monthly vs. Darbepoetin Alfa Given According to Local Label in Patients With Chronic Kidney Disease Who Are Not on Dialysis. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Mircera, Darbepoetin alfa |
| Enrollment | 228 |
| Start date | Sep 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Mar 2, 2007 |
| Last update posted | Dec 19, 2011 |
| Countries | Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Italy, Poland, Spain, United Kingdom and 1 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: